Biotech Stock Plunges on Bitcoin Plans as Ethereum Treasuries Stay Hot
Lixte Biotechnology's share price fell hard after it revealed a Bitcoin treasury, while firms stashing Ethereum have been surging of late.
Original source
Read on DecryptRelated market context
Bybit, Binance and Bitget Cancel Tokenized SpaceX Allocations as xStocks Fails to Deliver Shares
Three major crypto exchanges canceled their tokenized SpaceX IPO allocation campaigns Friday after xStocks could not source the un...
SpaceX’s IPO exposes the first crack in tokenized stocks – fragmented ownership and allocation
SpaceX priced its IPO at $135 per share on June 11, raised $75 billion in the largest public offering in history, and opened on Na...
SEC Plan to Scrap Rule 611 Could Be the Biggest Regulatory Unlock Yet for Crypto Tokenized US Stocks
The SEC just removed the single biggest legal obstacle standing between Crypto DeFi and US equity markets. On June 11, the agency...
Crypto exchanges are opening a two-front war for the stock market
Binance, Kraken, Bybit, and Gemini are moving to add US stocks and ETFs to their crypto trading apps, making a direct play for the...
Tether USDT Briefly Overtakes Ethereum in Market Cap: A $187B Wake-Up Call
For a few hours, earlier this week, Tether USDT stablecoin held a higher market cap than Ethereum, the first time that has happene...
Bitcoin price faces new risk as big buyers lose conviction
Bitcoin’s largest buyers are no longer behaving like a reliable backstop for the largest cryptocurrency. The exchange-traded funds...